C

CorMedix
D

CRMD

11.725
USD
0.39
(3.40%)
مغلق
حجم التداول
0
الربح لكل سهم
1
العائد الربحي
-
P/E
47
حجم السوق
872,681,971
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 9 أشهر
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
0.76500
(14.85%)
5.91500 USD
A
AKBA
-0.02500
(-0.63%)
3.97000 USD
C
CLRB
0.21000
(4.37%)
5.02000 USD
D
DVAX
0.090
(0.83%)
10.890 USD
M
MDGL
5.75
(1.86%)
314.53 USD
R
RDHL
0.03300
(1.57%)
2.13000 USD
R
RMTI
0.13000
(11.30%)
1.28000 USD
S
SNDX
0.58000
(6.27%)
9.83000 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.